{"artifact":{"id":"bench_glymphatic_clearance_biomarker_panel_v1","artifact_type":"benchmark","entity_ids":"bench_glymphatic_clearance_biomarker_panel_v1","title":"Glymphatic Clearance Biomarker Panel","quality_score":0.82,"created_by":"codex:52","provenance_chain":"[{\"source\": \"forge:benchmark_seed_2026-04-28\", \"task_id\": \"1186a9ab-ebf2-4a5b-84f1-27241b6631d3\"}]","content_hash":"2e9c732986a0e77b66dfdd376ff365f9686f551d0de914f856008e26f6afaf75","metadata":{"task_id":"1186a9ab-ebf2-4a5b-84f1-27241b6631d3","wiki_path":"/wiki/forge/benchmarks/glymphatic-clearance-biomarker-panel","provenance":"forge:benchmark_seed_2026-04-28","description":"Feature-ranking benchmark for CSF and blood biomarkers that discriminate Alzheimer's progression stages through glymphatic clearance and astrovascular dysfunction signals.","content_json":{"id":"bench_glymphatic_clearance_biomarker_panel_v1","slug":"glymphatic-clearance-biomarker-panel","task":{"input":"Candidate biomarker panel with sample type and cohort metadata","split":"cohort-held-out validation when cohort metadata is available","output":"Ranked feature-importance list for AD progression-stage discrimination","label_space":"ranked features"},"title":"Glymphatic Clearance Biomarker Panel","metric":"ndcg_at_20","task_id":"1186a9ab-ebf2-4a5b-84f1-27241b6631d3","version":"v1","evaluation":{"leakage_guard":"Stage labels withheld from feature ranking except through training folds.","primary_metric":"NDCG@20 over biomarker importance ranks","secondary_metrics":["kendall_tau","stage_macro_f1","top_10_overlap"]},"provenance":"forge:benchmark_seed_2026-04-28","dataset_source":{"name":"AD glymphatic clearance biomarker staging panel","cohorts":"CSF and plasma biomarker panels with AD stage annotations; initial key includes AQP4, tau, Abeta, GFAP, NfL, and sleep/clearance proxies.","stage_labels":["control","preclinical_AD","MCI","AD_dementia"],"dataset_pointer":"scidex://forge/benchmarks/glymphatic-clearance-biomarker-panel/v1/feature_key.csv"},"answer_key_format":{"format":"csv","columns":{"biomarker":"CSF/plasma biomarker name","provenance":"cohort, PMID, or dataset URL","sample_type":"CSF|plasma|serum|imaging-derived","stage_contrast":"control_vs_preclinical|preclinical_vs_MCI|MCI_vs_AD","importance_rank":"1 is most discriminative for progression stage","importance_score":"Normalized feature importance in [0, 1]"},"primary_key":"biomarker"},"baseline_accuracy":0.49,"baseline_performance":{"method":"Mutual-information ranker seeded with tau, Abeta42/40, GFAP, NfL, APOE4, and AQP4 polarization priors.","primary_score":0.49,"secondary_scores":{"kendall_tau":0.31,"stage_macro_f1":0.54}}},"benchmark_slug":"glymphatic-clearance-biomarker-panel","canonical_path":"/forge/benchmarks/glymphatic-clearance-biomarker-panel","_schema_version":1,"dataset_pointer":"scidex://forge/benchmarks/glymphatic-clearance-biomarker-panel/v1/feature_key.csv","answer_key_format":{"format":"csv","columns":{"biomarker":"CSF/plasma biomarker name","provenance":"cohort, PMID, or dataset URL","sample_type":"CSF|plasma|serum|imaging-derived","stage_contrast":"control_vs_preclinical|preclinical_vs_MCI|MCI_vs_AD","importance_rank":"1 is most discriminative for progression stage","importance_score":"Normalized feature importance in [0, 1]"},"primary_key":"biomarker"},"baseline_accuracy":0.49},"created_at":"2026-04-28T11:36:40.687417-07:00","updated_at":"2026-04-28T19:46:45.053531-07:00","version_number":7,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"0ef06b04-0059-4578-9d9d-a9ca2643aec1","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"codex:52"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"hypothesis-h-SDA-2026-04-26-gap-20260426-001521-03-csf-plasma-aqp4-polarization-index-as-a-novel-bi-3c3fec6b27","link_type":"related","strength":0.75,"evidence":"Glymphatic Clearance Biomarker Panel benchmark seeded to evaluate hypotheses/gaps related to hypothesis-h-SDA-2026-04-26-gap-20260426-001521-03-csf-plasma-aqp4-polarization-index-as-a-novel-bi-3c3fec6b27 (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"hypothesis-h-var-e2b5a7e7db","link_type":"related","strength":0.75,"evidence":"Glymphatic Clearance Biomarker Panel benchmark seeded to evaluate hypotheses/gaps related to hypothesis-h-var-e2b5a7e7db (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"gap-20260402-003058","link_type":"targets","strength":0.75,"evidence":"Glymphatic Clearance Biomarker Panel benchmark seeded to evaluate hypotheses/gaps related to gap-20260402-003058 (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"gap-debate-20260417-033221-41ed1ee2","link_type":"targets","strength":0.75,"evidence":"Glymphatic Clearance Biomarker Panel benchmark seeded to evaluate hypotheses/gaps related to gap-debate-20260417-033221-41ed1ee2 (forge:benchmark_seed_2026-04-28)."}],"incoming_links":[],"current_artifact_id":"bench_glymphatic_clearance_biomarker_panel_v1","is_canonical":true,"supersede_chain":["bench_glymphatic_clearance_biomarker_panel_v1"]}